7 Oct 2024 Gastroenterology & Hepatology Elafibranor Efficacy and Safety in People with Primary Biliary Cholangitis
18 Sep 2024 Oncology & Hematology HERTHENA-Lung02: Phase III clinical trial of patritumab deruxtecan in advanced EGFR-mutated NSCLC following EGFR TKI therapy
15 Aug 2024 Oncology & Hematology Analysis of patients’ side effects and quality of life in the ADAURA study
28 Jun 2024 Immunology & Immunotherapy A Video Summary of the Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis
11 Jan 2024 Oncology & Hematology Xevinapant + chemoradiotherapy in LA SCCHN: extended follow-up of a phase II clinical trial
24 Oct 2023 Oncology & Hematology P-REALITY-X: Real-world evaluation of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer
24 Oct 2023 Oncology & Hematology P-REALITY-X: Real-world evaluation of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer
18 Sep 2024 Oncology & Hematology HERTHENA-Lung02: Phase III clinical trial of patritumab deruxtecan in advanced EGFR-mutated NSCLC following EGFR TKI therapy
19 Jul 2023 Oncology & Hematology Hedgehog inhibitors for basal cell carcinoma: real-world treatment patterns
22 Nov 2021 Rare Diseases Plain language summary: Vosoritide treatment accelerates bone growth in children with achondroplasia
28 Jun 2024 Immunology & Immunotherapy A Video Summary of the Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis